These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 10753503

  • 1. Nitric-oxide-dependent systemic immunosuppression in animals with progressively growing malignant gliomas.
    Hegardt P, Widegren B, Sjögren HO.
    Cell Immunol; 2000 Mar 15; 200(2):116-27. PubMed ID: 10753503
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized with IFN-gamma-secreting glioma cells.
    Badn W, Hegardt P, Fellert MA, Darabi A, Esbjörnsson M, Smith KE, Janelidze S, Salford LG, Visse E, Siesjö P.
    Scand J Immunol; 2007 Mar 15; 65(3):289-97. PubMed ID: 17309784
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo effects of mercuric chloride on thymic endocrine activity, NK and NKT cell cytotoxicity, cytokine profiles (IL-2, IFN-gamma, IL-6): role of the nitric oxide-L-arginine pathway.
    Santarelli L, Bracci M, Mocchegiani E.
    Int Immunopharmacol; 2006 Mar 15; 6(3):376-89. PubMed ID: 16428073
    [Abstract] [Full Text] [Related]

  • 4. Rat splenocytes inhibit antigen-specific lymphocyte proliferation through a reactive nitrogen intermediate (RNI)-dependent mechanism and exhibit increased RNI production in response to IFN-gamma.
    Stein CS, Strejan GH.
    Cell Immunol; 1993 Sep 15; 150(2):281-97. PubMed ID: 8370073
    [Abstract] [Full Text] [Related]

  • 5. Burn-induced immunosuppression: attenuated T cell signaling independent of IFN-gamma- and nitric oxide-mediated pathways.
    Duan X, Yarmush D, Leeder A, Yarmush ML, Mitchell RN.
    J Leukoc Biol; 2008 Feb 15; 83(2):305-13. PubMed ID: 18024716
    [Abstract] [Full Text] [Related]

  • 6. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM, Okada H, Brissette-Storkus CS, Villa LA, Attanucci J, Lotze MT, Pollack IF, Bozik ME, Chambers WH.
    Cancer Res; 2000 May 01; 60(9):2449-57. PubMed ID: 10811123
    [Abstract] [Full Text] [Related]

  • 7. Low-dose combretastatin A4 phosphate enhances the immune response of tumor hosts to experimental colon carcinoma.
    Badn W, Kalliomäki S, Widegren B, Sjögren HO.
    Clin Cancer Res; 2006 Aug 01; 12(15):4714-9. PubMed ID: 16899622
    [Abstract] [Full Text] [Related]

  • 8. Nitric oxide production from a macrophage cell line: interaction with autologous and allogeneic lymphocytes.
    Isobe K, Nakashima I.
    J Cell Biochem; 1993 Nov 01; 53(3):198-205. PubMed ID: 8263036
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide contributes to the development of a post-injury Th2 T-cell phenotype and immune dysfunction.
    Daniel T, Alexander M, Hubbard WJ, Chaudry IH, Choudhry MA, Schwacha MG.
    J Cell Physiol; 2006 Aug 01; 208(2):418-27. PubMed ID: 16642464
    [Abstract] [Full Text] [Related]

  • 10. Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma.
    Hegardt P, Widegren B, Li L, Sjögren B, Kjellman C, Sur I, Sjögren HO.
    Cancer Immunol Immunother; 2001 Nov 01; 50(9):491-501. PubMed ID: 11761444
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide involvement in tumor-induced immunosuppression.
    Lejeune P, Lagadec P, Onier N, Pinard D, Ohshima H, Jeannin JF.
    J Immunol; 1994 May 15; 152(10):5077-83. PubMed ID: 7513729
    [Abstract] [Full Text] [Related]

  • 12. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H, Zheng X, Lou D, Zhang L, Zhang R, Sun R, Tian Z.
    Mol Immunol; 2005 May 15; 42(9):1023-31. PubMed ID: 15829292
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
    Alvarez V, Lodillinsky C, Umerez S, Sandes E, Eiján AM.
    Int J Mol Med; 2005 Oct 15; 16(4):565-71. PubMed ID: 16142388
    [Abstract] [Full Text] [Related]

  • 14. Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas.
    Yang T, Witham TF, Villa L, Erff M, Attanucci J, Watkins S, Kondziolka D, Okada H, Pollack IF, Chambers WH.
    Cancer Res; 2002 May 01; 62(9):2583-91. PubMed ID: 11980653
    [Abstract] [Full Text] [Related]

  • 15. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y, Yamaura A, Sakiyama S, Sato Y, Tagawa M.
    Int J Oncol; 2003 Aug 01; 23(2):483-8. PubMed ID: 12851699
    [Abstract] [Full Text] [Related]

  • 16. The radiosensitizing effect of immunoadjuvant OM-174 requires cooperation between immune and tumor cells through interferon-gamma and inducible nitric oxide synthase.
    De Ridder M, Verovski VN, Chiavaroli C, Van den Berge DL, Monsaert C, Law K, Storme GA.
    Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1473-80. PubMed ID: 17056198
    [Abstract] [Full Text] [Related]

  • 17. Involvement of nitric oxide in anti-tumor effects of OK-432, a streptococcal anti-tumor immunotherapeutic agent.
    Oshikawa T, Okamoto M, Tano T, Uddin Ahmed S, Sasai A, Kan S, Moriya Y, Ryoma Y, Saito M, Sato M.
    Int Immunopharmacol; 2006 May 01; 6(5):764-73. PubMed ID: 16546707
    [Abstract] [Full Text] [Related]

  • 18. Generation of cytotoxic immune responses during the progression of a rat glioma.
    Holladay FP, Choudhuri R, Heitz T, Wood GW.
    J Neurosurg; 1994 Jan 01; 80(1):90-6. PubMed ID: 8271027
    [Abstract] [Full Text] [Related]

  • 19. Adenosine rescues glioma cells from cytokine-induced death by interfering with the signaling network involved in nitric oxide production.
    Isakovic A, Harhaji L, Dacevic M, Trajkovic V.
    Eur J Pharmacol; 2008 Sep 04; 591(1-3):106-13. PubMed ID: 18606162
    [Abstract] [Full Text] [Related]

  • 20. Increased proportion of CD8+ tumor responsive T cells after immunization with tum- versus tum+ rat glioma.
    Siesjö P, Visse E, Sjögren HO.
    Cell Immunol; 1995 Oct 15; 165(2):225-33. PubMed ID: 7553887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.